Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-Cell Lymphoma (DLBCL)

Explore clinical trials studying Diffuse Large B-Cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.

45 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-Cell Lymphoma (DLBCL) trial results

Completed

A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

NCT05665530

Conditions
Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
Locations
  • City of Hope Duarte, California, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View all 24 locations
View Trial Details
Completed

A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

NCT05364424

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • Memorial Cancer Institute at Memorial West Pembroke Pines, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
  • Tulane Medical Center New Orleans, Louisiana, United States
View Trial Details
Completed

A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

NCT02875548

Conditions
Adenoma, Advanced Solid Tumors, Diffuse Large B-Cell Lymphoma (DLBCL), +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • California Cancer Associates For Research And Excellence, cCARE Santa Fe, California, United States
  • Hematology Oncology Associates of the Treasure Coast - Port St. Lucie Port Saint Lucie, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 34 locations
View Trial Details
Completed

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00001337

Conditions
Anaplastic Large-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +21 more
Locations
  • Holy Cross Hospital, Fort Lauderdale Fort Lauderdale, Florida, United States
  • University of Maryland, Baltimore Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

NCT04537715

Conditions
Adenoma, Advanced Malignancies, All Malignancies, +32 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details
Completed

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

NCT02445248

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • UCSF Medical Center . San Francisco, California, United States
  • Emory University School of Medicine/Winship Cancer Institute SC CTL019 Atlanta, Georgia, United States
  • University of Chicago Medical Center Hematology and Oncology SC - CTL019B2207J Chicago, Illinois, United States
  • University of Kansas Cancer Center SC - CTL019C2201 Westwood, Kansas, United States
View all 26 locations
View Trial Details
Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT03329950

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
Locations
  • HonorHealth Research Insititute Scottsdale, Arizona, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View Trial Details
Completed

A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13

NCT00400478

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Follicular NHL Grade 3b, Hemic and Lymphatic Diseases, +10 more
Locations
  • Border Medical Oncology Wodonga, Victoria, Australia
  • Concord Repatriation General Hospital Concord, Australia
  • Gosford Hospital Gosford, Australia
  • Greenslopes Hospital Greenslopes, Australia
View all 131 locations
View Trial Details

Related conditions